图书馆订阅: Guest
真核基因表达评论综述™

每年出版 6 

ISSN 打印: 1045-4403

ISSN 在线: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Gene Therapy: Basic Concepts and Recent Advances

卷 6, 册 1, 1996, pp. 29-57
DOI: 10.1615/CritRevEukarGeneExpr.v6.i1.30
Get accessGet access

摘要

After years of preliminary in vitro and in vivo modeling, the first human gene therapy clinical trial was initiated ∼5 years ago. The experience gained from this trial, and the others that have come after it, has shown that effective and efficient human gene therapy remains a tantalizing but elusive goal. Nevertheless, interest in this area of therapeutics continues to grow and over 100 gene therapy protocols have now been submitted to the Recombinant DNA Advisory Committee ("RAC") of the National Institutes of Health for approval. The goal of these protocols vary, but include correction of inherited gene defects, engineering new traits into cells such as diminished chemosensitivity in the case of bone marrow cells, or, in the case of tumor cells, expression of new immunophenotypes. Marking cells with a gene whose function can easily be detected, thereby rendering the cell traceable in vitro and in vivo is also the goal of several clinical trials. At the same time, different means of gene transfer are been investigated for the efficiency with which they deliver "therapeutic nucleotides" into their cellular targets. In this review, we recount some of the major developments that have occurred in these various areas and discuss their impact on progess in the field.

对本文的引用
  1. WONG K.K., CHATTERJEE SASWATI, Parvovirus Vectors for the Gene Therapy of Cancer, in Gene Therapy of Cancer, 2002. Crossref

  2. Li Lei, He Da-lin, Transfection of promyelocytic leukemia in retrovirus vector inhibits growth of human bladder cancer cells, Acta Pharmacologica Sinica, 26, 5, 2005. Crossref

  3. Duncan James R., Hicks Marshall E., Cai Shi-Rong, Brunt Elizabeth M., Ponder Katherine P., Embolization of Portal Vein Branches Induces Hepatocyte Replication in Swine: A Potential Step in Hepatic Gene Therapy, Radiology, 210, 2, 1999. Crossref

  4. Senmaru Naoto, Shichinohe Toshiaki, Takeuchi Motoya, Miyamoto Masaki, Sazawa Ataru, Ogiso Yoshifumi, Takahashi Toshiyuki, Okushiba Shyunichi, Takimoto Masato, Kato Hiroyuki, Kuzumaki Noboru, Suppression of Erk activation andin vivo growth in esophageal cancer cells by the dominant negativeRas mutant, N116Y, International Journal of Cancer, 78, 3, 1998. Crossref

  5. Dev S.B., Rabussay D.P., Widera G., Hofmann G.A., Medical applications of electroporation, IEEE Transactions on Plasma Science, 28, 1, 2000. Crossref

  6. Goomer R.S., Deftos L.J., Terkeltaub R., Maris T., Lee M.C., Harwood F.L., Amiel D., High-efficiency non-viral transfection of primary chondrocytes and perichondrial cells for ex-vivo gene therapy to repair articular cartilage defects, Osteoarthritis and Cartilage, 9, 3, 2001. Crossref

  7. Winn Shelley R, Hu Yunhua, Sfeir Charles, Hollinger Jeffrey O, Gene therapy approaches for modulating bone regeneration, Advanced Drug Delivery Reviews, 42, 1-2, 2000. Crossref

  8. Wunderbaldinger Patrick, Bogdanov Alexei, Weissleder Ralph, New approaches for imaging in gene therapy, European Journal of Radiology, 34, 3, 2000. Crossref

  9. Wang Fubao, Raab R.Michael, Washabaugh Michael W., Buckland Barry C., Gene Therapy and Metabolic Engineering, Metabolic Engineering, 2, 2, 2000. Crossref

  10. Liu Y., Yang H., Sakanishi A., Ultrasound: Mechanical gene transfer into plant cells by sonoporation, Biotechnology Advances, 24, 1, 2006. Crossref

  11. Greenleaf William J., Bolander Mark E., Sarkar Gobinda, Goldring Mary B., Greenleaf James F., Artificial Cavitation Nuclei Significantly Enhance Acoustically Induced Cell Transfection, Ultrasound in Medicine & Biology, 24, 4, 1998. Crossref

  12. Khavari Paul A., Gene Therapy for Genetic Skin Disease, Journal of Investigative Dermatology, 110, 4, 1998. Crossref

  13. JEONG YEON WOO, LEE GEUN-SHIK, KIM JOUNG JOO, PARK SUN WOO, KO KYEONG HEE, KANG MINA, KIM YU KYUNG, JUNG EUI-MAN, HYUN SANG HWAN, SHIN TAEYOUNG, JEUNG EUI-BAE, HWANG WOO SUK, Establishment of a canine model of human type 2 diabetes mellitus by overexpressing phosphoenolypyruvate carboxykinase, International Journal of Molecular Medicine, 30, 2, 2012. Crossref

  14. LEE GEUN-SHIK, JEONG YEON WOO, KIM JOUNG JOO, PARK SUN WOO, KO KYEONG HEE, KANG MINA, KIM YU KYUNG, JUNG EUI-MAN, MOON CHANGJONG, HYUN SANG HWAN, HWANG KYU-CHAN, KIM NAM-HYUNG, SHIN TAEYOUNG, JEUNG EUI-BAE, HWANG WOO SUK, A canine model of Alzheimer’s disease generated by overexpressing a mutated human amyloid precursor protein, International Journal of Molecular Medicine, 33, 4, 2014. Crossref

  15. Ciccolini Laura A. S., Shamlou Parviz Ayazi, Titchener-Hooker Nigel, A mass balance study to assess the extent of contaminant removal achieved in the operations for the primary recovery of plasmid DNA fromEscherichia coli cells, Biotechnology and Bioengineering, 77, 7, 2002. Crossref

  16. Goomer Randal S., Maris Thira M., Gelberman Richard, Boyer Marty, Silva Matt, Amiel David, Nonviral In Vivo Gene Therapy for Tissue Engineering of Articular Cartilage and Tendon Repair, Clinical Orthopaedics and Related Research, 379, 2000. Crossref

  17. Goomer Randal S., Amiel David, Nonviral Gene Therapy: Application in the Repair of Osteochondral Articular Defects, in Gene Therapy and Tissue Engineering in Orthopaedic and Sports Medicine, 2000. Crossref

  18. Upegui-Gonzalez Lia C., François Jean-Christophe, Ly Adama, Trojan Jerzy, The Approach of Triple Helix Formation in Control of Gene Expression and The Treatment of Tumors Expressing IGF-I, in Cancer Gene Therapy, 465, 2002. Crossref

  19. Van Montfrans C., Hove T. Ten, Van Deventer S. J. H., Immunomodulation of Crohn’s disease, in Trends in Inflammatory Bowel Disease Therapy 1999, 2000. Crossref

  20. Xiang Qing, Qin Peter Zhifeng, Michels William J., Freeland Keri, Pyle Anna Marie, Sequence Specificity of a Group II Intron Ribozyme:  Multiple Mechanisms for Promoting Unusually High Discrimination against Mismatched Targets, Biochemistry, 37, 11, 1998. Crossref

  21. Chen Q.M., Tu V.C., Catania J., Burton M., Toussaint O., Dilley T., Involvement of Rb family proteins, focal adhesion proteins and protein synthesis in senescent morphogenesis induced by hydrogen peroxide, Journal of Cell Science, 113, 22, 2000. Crossref

  22. Hou Zhen, Nguyen Que, Frenkel Baruch, Nilsson Susan K., Milne Moira, van Wijnen André J., Stein Janet L., Quesenberry Peter, Lian Jane B., Stein Gary S., Osteoblast-specific gene expression after transplantation of marrow cells: Implications for skeletal gene therapy, Proceedings of the National Academy of Sciences, 96, 13, 1999. Crossref

  23. Schellingerhout D, Rainov N G, Breakefield X O, Weissleder R, Quantitation of HSV mass distribution in a rodent brain tumor model, Gene Therapy, 7, 19, 2000. Crossref

将发表的论文

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain